Mild Hereditary Factor VIII Deficiency Disease Without Inhibitor

Explore clinical trials studying Mild Hereditary Factor VIII Deficiency Disease Without Inhibitor. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Mild Hereditary Factor VIII Deficiency Disease Without Inhibitor trial results

Completed

A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Emicizumab in Participants With Mild or Moderate Hemophilia A Without FVIII Inhibitors

NCT04158648

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations: Childrens Hospital LA Los Angeles, California, United States

Hemophilia of Georgia Center for Bleeding & Clotting Disorders Atlanta, Georgia, United States

Indiana Hemophilia & Thrombosis center Indianapolis, Indiana, United States

University of Michigan, C.S. Mott Children's Hospital Ann Arbor, Michigan, United States

View all 22 locations

View Trial Details

Mild Hereditary Factor VIII Deficiency Disease Without Inhibitor

Mild Hereditary Factor VIII Deficiency Disease Without Inhibitor trial results

A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Emicizumab in Participants With Mild or Moderate Hemophilia A Without FVIII Inhibitors

Related conditions